首页 文献索引 SCI期刊 AI助手
首页 正文

Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability

{{output}}